Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
- 1 April 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8901) , 816-819
- https://doi.org/10.1016/s0140-6736(94)92024-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis.BMJ, 1993
- Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction.Circulation, 1992
- Cumulative Meta-Analysis of Therapeutic Trials for Myocardial InfarctionNew England Journal of Medicine, 1992
- Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1992
- Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.BMJ, 1991
- Magnesium for acute myocardial infarction?The Lancet, 1991
- Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortalityInternational Journal of Cardiology, 1986
- INTRAVENOUS MAGNESIUM IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1986
- Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival.Circulation, 1979
- Myocardial protection during ischemic cardiac arrestThe Journal of Thoracic and Cardiovascular Surgery, 1978